Trademark Overview
On Monday, June 24, 2024, a trademark application was filed for CYTEGRITY with the United States Patent and Trademark Office. The USPTO has given the CYTEGRITY trademark a serial number of 98615749. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 24, 2024. This trademark is owned by CSL Behring Gene Therapy, Inc.. The CYTEGRITY trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacture of pharmaceuticals based on cell therapy and gene therapy; Custom manufacture of medicine, namely, personalized medicine for others based on unique characteristics and conditions of the patient
Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare
Research and development services relating to viral vectors, cell therapies, gene therapies, and medicines; Development of pharmaceutical preparations, viral vectors, cell therapies, gene therapies, and medicines; Stem cell research services; Stem cell gene therapy services, namely, advanced inducible stable producer technology research services designed specifically for the production of lentiviral vectors; Gene therapy research; Testing, inspection, research or development of pharmaceutical preparations for gene therapy
